We are live on ! Find out more
LIP

Lighthouse Investment Partners Portfolio holdings

AUM $2.87B
1-Year Est. Return 26.77%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+26.77%
3 Year Est. Return
+78.45%
5 Year Est. Return
10 Year Est. Return
AUM
$3.33B
AUM Growth
+$33.5M
Cap. Flow
+$10.4M
Cap. Flow %
0.31%
Top 10 Hldgs %
14.59%
Holding
1,090
New
494
Increased
167
Reduced
178
Closed
228

Top Buys

Rank Stock Value
1
SYY icon
Sysco
SYY
+$27.7M
2
FRPT icon
Freshpet
FRPT
+$21.1M
3
CELH icon
Celsius Holdings
CELH
+$20.6M
4
FIX icon
Comfort Systems
FIX
+$20.3M
5
H icon
Hyatt Hotels
H
+$20.2M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$24.5M
2
WMT icon
Walmart Inc
WMT
+$23.6M
3
AVGO icon
Broadcom
AVGO
+$23.6M
4
RNR icon
RenaissanceRe
RNR
+$23.5M
5
T icon
AT&T
T
+$19.4M

Sector Composition

Rank Sector Weight
1 Financials 19.29%
2 Real Estate 15.11%
3 Consumer Discretionary 11.82%
4 Energy 10.43%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIX icon
851
Anixa Biosciences
ANIX
$116M
$53K ﹤0.01%
+16,980
New +$69.5K
IMMX icon
852
Immix Biopharma
IMMX
$692M
$52.4K ﹤0.01%
+10,020
New +$41.2K
RPID icon
853
Rapid Micro Biosystems
RPID
$86.2M
$45.6K ﹤0.01%
+15,720
New +$54.6K
BTCS icon
854
BTCS Inc
BTCS
$55.3M
$45K ﹤0.01%
+17,040
New +$61.5K
AIFC
855
AI Financial Corp
AIFC
$61.3M
$43.6K ﹤0.01%
+39,600
New +$76.3K
OACCW
856
Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
$42.6K ﹤0.01%
60,000
CDLX icon
857
Cardlytics
CDLX
$21.5M
$42K ﹤0.01%
3,656
CGTX icon
858
Cognition Therapeutics
CGTX
$96.7M
$39.9K ﹤0.01%
+29,580
New +$48K
STEX
859
Streamex Corp
STEX
$83M
$35.3K ﹤0.01%
+11,640
New +$52.1K
PYXS icon
860
Pyxis Oncology
PYXS
$236M
$33.2K ﹤0.01%
+28,860
New +$102K
UPXI icon
861
Upexi
UPXI
$62.5M
$30.5K ﹤0.01%
+18,180
New +$68.6K
VTGN icon
862
VistaGen Therapeutics
VTGN
$12.8M
$13.6K ﹤0.01%
+20,580
New +$74.3K
ACLX
863
DELISTED
Arcellx
ACLX
-10,500
Closed -$862K
ADBE icon
864
Adobe
ADBE
$105B
-780
Closed -$275K
ADI icon
865
Analog Devices
ADI
$190B
-1,180
Closed -$290K
ADSK icon
866
Autodesk
ADSK
$52.6B
-18,033
Closed -$5.73M
AG icon
867
First Majestic Silver
AG
$9.07B
-83,077
Closed -$1.02M
AGCO icon
868
AGCO
AGCO
$7.2B
-21,000
Closed -$2.25M
AIG icon
869
American International
AIG
$41.3B
-53,805
Closed -$4.23M
AIR icon
870
AAR Corp
AIR
$5.76B
-4,598
Closed -$412K
AKRO
871
DELISTED
Akero Therapeutics
AKRO
-20,000
Closed -$950K
ALE
872
DELISTED
Allete
ALE
-156,022
Closed -$10.4M
ALL icon
873
Allstate
ALL
$67.5B
-83,266
Closed -$17.9M
ALLY icon
874
CALL
Ally Financial
ALLY
$13.3B
-40,000
Closed -$1.57M
ALLY icon
875
PUT
Ally Financial
ALLY
$13.3B
-50,000
Closed -$1.96M

Similar funds

Lighthouse Investment Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Lighthouse Investment Partners held 1,090 positions worth $3.33B, up 1% from $3.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Lighthouse Investment Partners's Q4 2025 filing shows 494 new, 167 increased, 178 reduced and 228 closed positions. Its largest new stake was Freshpet: 371,792 shares worth $22.7M. The largest sale was Morgan Stanley, an estimated $24.5M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 22% a quarter earlier, followed by Real Estate and Consumer Discretionary.

  • Lighthouse Investment Partners's largest Q4 2025 buy was Freshpet: 371,792 shares worth $22.7M.
  • Lighthouse Investment Partners added most to Sysco in Q4 2025, an estimated $27.7M increase.
  • Lighthouse Investment Partners's biggest Q4 2025 reduction was Morgan Stanley, cutting an estimated $24.5M.
  • Lighthouse Investment Partners fully exited Broadcom in Q4 2025, selling an estimated $23.6M.
  • Lighthouse Investment Partners's ten largest holdings make up 15% of its $3.33B portfolio in Q4 2025.
  • Lighthouse Investment Partners opened 494 new positions and closed 228 in Q4 2025.
  • Lighthouse Investment Partners's portfolio value rose 1% quarter-over-quarter to $3.33B.

Based on Lighthouse Investment Partners's 13F filing for Q4 2025, filed 17 Feb 2026.